126131008: Rivastigmine tartrate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Acetylcholinesterase inhibitor\...

\Centrally acting acetylcholinesterase inhibitor\Rivastigmine tartrate

\Reversible anticholinesterase\Rivastigmine tartrate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Parasympathomimetic agent (substance)\Acetylcholinesterase inhibitor\Centrally acting acetylcholinesterase inhibitor\Rivastigmine tartrate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Parasympathomimetic agent (substance)\Acetylcholinesterase inhibitor\Reversible anticholinesterase\Rivastigmine tartrate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Rivastigmine tartrate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Carbamate (substance)\Carbamate ester (substance)\Phenylcarbamate (substance)\Rivastigmine tartrate

\Ester\Carbamate ester (substance)\Phenylcarbamate (substance)\Rivastigmine tartrate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Rivastigmine tartrate	Is a	Product containing reversible anticholinesterase (product)	false	Inferred relationship	Some
Rivastigmine tartrate	Is a	Reversible anticholinesterase	true	Inferred relationship	Some
Rivastigmine tartrate	Is a	Rivastigmine (substance)	false	Inferred relationship	Some
Rivastigmine tartrate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Acetylcholine receptor agonist (disposition)	false	Inferred relationship	Some
Rivastigmine tartrate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Cholinesterase inhibitor	false	Inferred relationship	Some
Rivastigmine tartrate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Centrally acting acetylcholinesterase inhibitor (disposition)	true	Inferred relationship	Some
Rivastigmine tartrate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Rivastigmine (substance)	true	Inferred relationship	Some
Rivastigmine tartrate	Is a	Phenylcarbamate (substance)	true	Inferred relationship	Some
Rivastigmine tartrate	Is a	Centrally acting acetylcholinesterase inhibitor	true	Inferred relationship	Some
Rivastigmine tartrate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Reversible anticholinesterase	true	Inferred relationship	Some
Rivastigmine tartrate	Is a	Central nervous system agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Rivastigmine (as rivastigmine tartrate) 2 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine tartrate	Inferred relationship	Some
Product containing precisely rivastigmine (as rivastigmine tartrate) 4.5 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine tartrate	Inferred relationship	Some
Product containing precisely rivastigmine (as rivastigmine tartrate) 1.5 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine tartrate	Inferred relationship	Some
Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine tartrate	Inferred relationship	Some
Rivastigmine (as rivastigmine tartrate) 6 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine tartrate	Inferred relationship	Some
Product containing precisely rivastigmine (as rivastigmine tartrate) 1.5 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine tartrate	Inferred relationship	Some	1
Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine tartrate	Inferred relationship	Some	1
Product containing precisely rivastigmine (as rivastigmine tartrate) 4.5 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine tartrate	Inferred relationship	Some	1
Rivastigmine (as rivastigmine tartrate) 6 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rivastigmine tartrate	Inferred relationship	Some	1
Product containing precisely rivastigmine (as rivastigmine tartrate) 1.5 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rivastigmine tartrate	Inferred relationship	Some	1
Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rivastigmine tartrate	Inferred relationship	Some	1
Product containing precisely rivastigmine (as rivastigmine tartrate) 4.5 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rivastigmine tartrate	Inferred relationship	Some	1
Rivastigmine (as rivastigmine tartrate) 6 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rivastigmine tartrate	Inferred relationship	Some	1
Rivastigmine (as rivastigmine tartrate) 2 mg/mL oral solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rivastigmine tartrate	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
15679013	Rivastigmine tartrate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
730055014	Rivastigmine tartrate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2696051016	Rivastigmine hydrogen tartrate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4842091000005117	rivastigminhydrogentartrat	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)